Skip to main content

Day: November 26, 2025

Barrick Completes Hemlo Transaction

All amounts expressed in U.S. dollars TORONTO, Nov. 26, 2025 (GLOBE NEWSWIRE) — Barrick Mining Corporation (NYSE:B)(TSX:ABX) (“Barrick” or the “Company”) announced today that it has completed the divestiture of the Hemlo Gold Mine (“Hemlo”) in Canada to Carcetti Capital Corp., to be renamed to Hemlo Mining Corp. (“HMC”), for a total consideration of up to $1.09 billion, inclusive of $875 million in cash received on closing, $50 million in HMC shares received on closing, and a production and tiered gold price-linked cash payment structure of up to $165 million starting in January 2027 for a five-year term1. The Company would like to thank the Biigtigong Nishnaabeg and the Netmizaaggamig Nishnaabeg First Nations for their cooperation and support related to the operation of Hemlo. About Barrick Mining Corporation Barrick is a leading...

Continue reading

FreightCar America, Inc. to Present at NobleCon21

CHICAGO, Nov. 26, 2025 (GLOBE NEWSWIRE) — FreightCar America, Inc. (NASDAQ: RAIL) (“FreightCar America” or the “Company”), a diversified manufacturer and supplier of railroad freight cars, railcar parts and components, today announced that Nick Randall, Chief Executive Officer, and Michael Riordan, Chief Financial Officer, will present and participate in one-on-one meetings with investors at Noble Capital Markets’ Emerging Growth Equity Conference on December 3, 2025 in Boca Raton, Florida. For additional information or to request a meeting, please contact the Company’s Investor Relations team at RAILIR@riveron.com. About FreightCar America FreightCar America, headquartered in Chicago, Illinois, is a leading designer, producer and supplier of railroad freight cars, railcar parts and components. We also specialize in railcar repairs,...

Continue reading

Quanex Building Products Announces Fourth Quarter and Full Year 2025 Earnings Release and Conference Call Schedule

HOUSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) — Quanex Building Products Corporation (NYSE: NX) (“Quanex” or the “Company”) today announced plans to release its fourth quarter and full year 2025 results on Thursday, December 11, 2025, after trading closes on the New York Stock Exchange. The Company has also scheduled a conference call for Friday, December 12, 2025, at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release.  A link to the live audio webcast will be available on Quanex’s website at http://www.quanex.com in the Investors section under Events & Presentations. Participants can pre-register for the conference call using the following link: https://register-conf.media-server.com/register/BI74e5fd99c2e14c3896a48692a347cd12 Registered participants will receive an email containing conference call details for dial-in options. ...

Continue reading

Northrim BanCorp, Inc. Announces Completion of $60.0 Million Subordinated Notes Offering

ANCHORAGE, Alaska, Nov. 26, 2025 (GLOBE NEWSWIRE) — Northrim BanCorp, Inc. (NASDAQ: NRIM). (“Northrim” or the “Company”) today announced the completion of its private placement of $60.0 million in aggregate principal amount of 6.875% Fixed-to-Floating Rate Subordinated Notes due 2035 (the “Notes”) to certain qualified institutional buyers and institutional accredited investors. The Notes bear interest at a fixed annual rate of 6.875% for the first five years and will reset quarterly thereafter to the then current three-month SOFR rate plus 348 basis points. The Notes are intended to qualify as Tier 2 capital for regulatory capital purposes for the Company. The Company intends to use the net proceeds from the private placement for general corporate purposes and to support regulatory capital ratios for growth initiatives. In connection...

Continue reading

Brookfield Infrastructure Announces Intention to Redeem its Series 3 Preferred Units

BROOKFIELD, News, Nov. 26, 2025 (GLOBE NEWSWIRE) — Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) today announced that it intends to redeem all of its outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”) (TSX: BIP.PR.B) for cash on December 31, 2025. The redemption price for each Series 3 Preferred Unit will be C$25.00. Holders of Series 3 Preferred Units of record as of November 28, 2025 will receive the previously declared final quarterly distribution of C$0.34375 per Series 3 Preferred Unit, payable on December 31, 2025. About Brookfield Infrastructure Brookfield Infrastructure is a leading global infrastructure company that owns and operates high-quality, long-life assets in the utilities, transport, midstream and data sectors across the Americas, Asia...

Continue reading

Methode Electronics Announces Second Quarter Fiscal 2026 Results Conference Call

CHICAGO, Nov. 26, 2025 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, lighting system, and power distribution applications, announced it will conduct a conference call and webcast on Thursday, December 4, 2025, at 10:00 a.m. CDT to review its second quarter fiscal 2026 results. President and Chief Executive Officer, Jon DeGaynor, and Chief Financial Officer, Laura Kowalchik will lead the call. The presentation will be webcast live on the company’s investor relations website at https://ir.methode.com. Participants are encouraged to log on to the webcast approximately 10 minutes before the start of the presentation. A replay of the webcast will be available on the investor relations website. About Methode Electronics, Inc.Methode Electronics,...

Continue reading

Tilray Brands Announces Implementation of Previously Approved 1-for-10 Reverse Stock Split

Common Stock Expected to Begin Trading on a Split-Adjusted Basis on December 2, 2025 NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray Brands”, “Tilray” or “the Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the global cannabis, beverage, and wellness industries, today announced that it will implement a one-for-ten reverse stock split of the Company’s common stock (the “Reverse Stock Split”), as previously approved at the special meeting of stockholders held on June 10, 2025. The Reverse Stock Split is expected to be effective at 4:01 pm Eastern Time on December 1, 2025 (the “Effective Date”) and shares of the Company’s common stock will begin trading on a split-adjusted basis under the same symbol (TLRY) when the markets open on December 2,...

Continue reading

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW HOPE, Pa., Nov. 26, 2025 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, reported today that, on November 24, 2025, the Compensation Committee of the Orchestra BioMed Board of Directors granted stock options to purchase an aggregate of 151,250 shares of the Company’s common stock to 12 newly hired employees. The awards were granted pursuant to the Orchestra Biomed Holdings, Inc. 2025 New Hire Inducement Plan as an inducement material to each new employee entering employment with Orchestra Biomed, in accordance with Nasdaq Listing Rule 5635(c)(4). Twenty-five percent of the stock options granted to each new employee...

Continue reading

Nutanix to Present at Upcoming Investor Conference

SAN JOSE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) — Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that its management will present at the following upcoming financial community event:Barclays 23rd Annual Global Technology ConferenceThursday, December 11, 202511:35 a.m. PST; 2:35 p.m. ESTA live webcast and replay of the presentation will be accessible on the Nutanix Investor Relations website at ir.nutanix.com About NutanixNutanix is a hybrid multicloud computing leader, offering organizations a unified software platform for running applications and AI and managing data anywhere. With Nutanix, organizations can simplify operations for traditional and modern applications, freeing them to focus on business goals. Trusted by more than 29,000 customers worldwide, Nutanix helps empower organizations...

Continue reading

Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

RADNOR, Pa., Nov. 26, 2025 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced today that on November 24, 2025, the Compensation Committee of Mineralys’ Board of Directors granted an inducement stock option award covering 146,000 shares of Mineralys common stock to one new non-executive employee. The award was granted under Mineralys’ 2025 Employment Inducement Incentive Award Plan, which provides for the granting of equity awards to new employees of Mineralys. The option will vest over a four-year period, with 25% of the total shares underlying the option vesting...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.